These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38698370)

  • 81. Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.
    Jin S; Ma H; Yang W; Ju H; Wang L; Zhang Z
    J Mol Med (Berl); 2018 Jun; 96(6):513-525. PubMed ID: 29713760
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.
    Hiroshima K; Shiiba M; Oka N; Hayashi F; Ishida S; Fukushima R; Koike K; Iyoda M; Nakashima D; Tanzawa H; Uzawa K
    Exp Cell Res; 2019 Nov; 384(2):111622. PubMed ID: 31518558
    [TBL] [Abstract][Full Text] [Related]  

  • 84. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 85. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.
    Gao L; Wang X; Wang X; Zhang L; Qiang C; Chang S; Ren W; Li S; Yang Y; Tong D; Chen C; Li Z; Song T; Zhi K; Huang C
    Oncotarget; 2014 May; 5(9):2562-74. PubMed ID: 24810113
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
    Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
    Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
    [TBL] [Abstract][Full Text] [Related]  

  • 87. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
    Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
    J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Roles of Wnt-1, beta-catenin and adenomatous polyposis coli in the differentiation and proliferation of oral squamous cell carcinoma].
    Zhang WM; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Nov; 40(6):491-4. PubMed ID: 16329837
    [TBL] [Abstract][Full Text] [Related]  

  • 91. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
    Li X; Ding R; Han Z; Ma Z; Wang Y
    Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.
    Hu S; Wang H; Yan D; Lu W; Gao P; Lou W; Kong X
    Cell Cycle; 2018; 17(18):2284-2295. PubMed ID: 30252587
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
    Kou Y; Zhang Y; Rong X; Yang P; Wang C; Zhou Q; Liu H; Liu B; Li M
    J Oral Biosci; 2023 Dec; 65(4):347-355. PubMed ID: 37625505
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
    Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
    [No Abstract]   [Full Text] [Related]  

  • 96. Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line.
    Bauer K; Dowejko A; Bosserhoff AK; Reichert TE; Bauer R
    Carcinogenesis; 2011 Jun; 32(6):935-43. PubMed ID: 21459757
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Effect of circular RNA hsa_circ_0063772 on proliferation, migration and invasion of oral squamous cell carcinoma cells].
    Wang F; Wang YF; Su W; Yang HJ; Yang HY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Aug; 54(8):561-567. PubMed ID: 31378036
    [No Abstract]   [Full Text] [Related]  

  • 98. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
    Peng XL; Ji MY; Yang ZR; Song J; Dong WG
    World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
    Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
    Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y; Zhong L; Duan D; Li T
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.